Clin Pediatr Hematol Oncol.  2018 Apr;25(1):66-70. 10.15264/cpho.2018.25.1.66.

A Case of Erdheim-Chester Disease Developed during Treatment of Leukemia in a Child

Affiliations
  • 1Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. CJ@yuhs.ac

Abstract

Erdheim-Chester disease (ECD) is a rare non-Langerhan's cell histiocytosis disorder characterized by replacement of normal tissue by lipid-laden histiocytes affecting various organs. A few pediatric cases have been reported worldwide. Here we present a child with leukemia who was diagnosed as ECD. A 2-year and 11-month old boy diagnosed with high risk acute lymphoblastic leukemia (ALL) at the age of 17 months, received allogeneic hematopoietic stem cell transplantation (HSCT) at the age of 2 years old. Six months after the transplantation, the patient was admitted to the hospital with palpable left calf nodules. Bone marrow study suggested ECD without leukemia with complete chimerism status. Excisional biopsy of the left calf nodule showed "˜aggregation of non-Langerhan's cell type epitheloid histiocytes'; clinically suggestive of ECD. The patient was started on vinblastine and corticosteroid treatment.

Keyword

Erdheim-Chester disease; Acute lymphoblastic leukemia; Child

MeSH Terms

Biopsy
Bone Marrow
Child*
Chimerism
Erdheim-Chester Disease*
Hematopoietic Stem Cell Transplantation
Histiocytes
Histiocytosis
Humans
Leukemia*
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Vinblastine
Vinblastine
Full Text Links
  • CPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr